• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

476.13 +0.28 (+0.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 214,813
Open 475.45
Bid (Size) 450.00 (40)
Ask (Size) 480.00 (2,000)
Prev. Close 475.85
Today's Range 469.83 - 479.14
52wk Range 266.98 - 519.99
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
United Therapeutics Corp. (NASDAQ:UTHR) Passes the "Caviar Cruise" Quality Investing Screen ↗
Today 7:51 EST
Via Chartmill
News headline image
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026
February 11, 2026
From United Therapeutics Corporation
Via Business Wire

Performance

YTD
-4.1%
-4.1%
1 Month
-1.3%
-1.3%
3 Month
+3.2%
+3.2%
6 Month
+53.7%
+53.7%
1 Year
+34.8%
+34.8%

More News

Read More
News headline image
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack
January 29, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
$100 Million Exit: Why One Fund Walked Away From a Chinese E-Commerce Stock Up 24% ↗
January 29, 2026
Via The Motley Fool
Topics Economy
News headline image
This Bank Stock Just Saw a $24 Million Fund Sale, but Here's Why It's Still a Top Holding ↗
January 29, 2026
Via The Motley Fool
Topics Credit Cards ETFs
News headline image
Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)
January 27, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
January 26, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
January 22, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
3 Market-Beating Stocks to Target This Week
January 15, 2026
Via StockStory
Topics Credit Cards Supply Chain
News headline image
Investment Advisor Doubles Down on Insurance Stock, According to Recent SEC Filing ↗
January 15, 2026
Via The Motley Fool
Topics Bonds Regulatory Compliance
News headline image
Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase ↗
January 15, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
2 Cash-Heavy Stocks to Target This Week and 1 We Question
January 11, 2026
Via StockStory
News headline image
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From United Therapeutics Corporation
Via Business Wire
News headline image
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers
December 21, 2025
Via StockStory
Topics Artificial Intelligence
News headline image
Why a $27 Million Buy Signals New Confidence in Weatherford Stock ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Signet Jewelers Gains New $25 Million Institutional Backer — Is the Stock a Buy? ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why a Value Fund Has a $29 Million Bet on Core Natural Resources Stock ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Is Kulicke and Soffa Stock a Buy Even as One Fund Dumps a $10 Million Stake? ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
United Therapeutics Corp (NASDAQ:UTHR): A Value Investing Case Study ↗
December 05, 2025
Via Chartmill
News headline image
United Therapeutics Corp (NASDAQ:UTHR): A Caviar Cruise Quality Investment ↗
November 26, 2025
Via Chartmill
News headline image
2 Mooning Stocks on Our Buy List and 1 That Underwhelm
November 21, 2025
Via StockStory
News headline image
Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today ↗
November 19, 2025
Via Benzinga
News headline image
United Therapeutics Corp (NASDAQ:UTHR) Presents a Compelling Value Investment Case ↗
November 12, 2025
Via Chartmill
News headline image
3 Reasons Investors Love United Therapeutics (UTHR)
November 09, 2025
Via StockStory
News headline image
Is United Therapeutics Corp Gaining or Losing Market Support? ↗
November 07, 2025
Via Benzinga

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 476.13
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 02/12/26 04:00 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 21.37B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap